Variant ID: 1-55505571-CTG-TGT

NM_174936.3(PCSK9):c.61_63delinsTGT;(p.L21C)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.

Scientific Reports
Chodorge, Matthieu M; Celeste, Anthony J AJ; Grimsby, Joseph J; Konkar, Anish A; Davidsson, Pia P; Fairman, David D; Jenkinson, Lesley L; Naylor, Jacqueline J; White, Nicholas N; Seaman, Jonathan C JC; Dickson, Karen K; Kemp, Benjamin B; Spooner, Jennifer J; Rossy, Emmanuel E; Hornigold, David C DC; Trevaskis, James L JL; Bond, Nicholas J NJ; London, Timothy B TB; Buchanan, Andrew A; Vaughan, Tristan T; Rondinone, Cristina M CM; Osbourn, Jane K JK
Publication Date: 2018-12-03

Variant appearance in text: PCSK9: L21C
PubMed Link: 30510163
Variant Present in the following documents:
  • Main text
View BVdb publication page